OneMedNet (NASDAQ:ONMD) Releases Quarterly Earnings Results

OneMedNet (NASDAQ:ONMD – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.43) earnings per share for the quarter, Zacks reports. The company had revenue of $1.02 million during the quarter.

OneMedNet Stock Down 9.8%

NASDAQ ONMD traded down $0.49 during mid-day trading on Wednesday, hitting $4.46. The stock had a trading volume of 16,750 shares, compared to its average volume of 164,370. The company has a 50 day simple moving average of $5.31 and a 200 day simple moving average of $6.95. The company has a market cap of $26.47 million, a price-to-earnings ratio of -2.79 and a beta of 1.25. OneMedNet has a 52-week low of $3.61 and a 52-week high of $23.00.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, OneMedNet has an average rating of “Sell”.

View Our Latest Report on ONMD

Insiders Place Their Bets

In other news, Director Thomas Kosasa purchased 129,758 shares of the company’s stock in a transaction dated Wednesday, October 7th. The stock was acquired at an average price of $5.78 per share, for a total transaction of $750,001.24. Following the completion of the transaction, the director directly owned 1,983,573 shares in the company, valued at $11,465,051.94. This represents a 7.00% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO Aaron Green sold 5,000 shares of OneMedNet stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $7.39, for a total value of $36,950.00. Following the transaction, the chief executive officer directly owned 249,638 shares of the company’s stock, valued at $1,844,824.82. This trade represents a 1.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have bought 189,169 shares of company stock worth $1,089,995 and have sold 15,167 shares worth $103,042. 50.20% of the stock is owned by company insiders.

OneMedNet Company Profile

(Get Free Report)

OneMedNet Corporation provides real-world data (RWD) for healthcare research. Through its iRWD platform, the company helps connect healthcare organizations that contribute medical information with pharmaceutical, biotechnology and medical-device companies seeking data for research and product development. Its offerings include curated, de-identified clinical records and medical imaging data. These datasets can support activities such as clinical research and the evaluation of medicines and medical devices, while the platform is designed to facilitate secure data access and collaboration.

Read More

Earnings History for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.